Your browser doesn't support javascript.
loading
Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1.
Perico, M E; Mezzanzanica, D; Luison, E; Alberti, P; Panza, L; Russo, G; Canevari, S.
Affiliation
  • Perico ME; Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy.
Cancer Immunol Immunother ; 49(6): 296-304, 2000 Aug.
Article in En | MEDLINE | ID: mdl-10946811
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligosaccharides / ABO Blood-Group System / Antigens, Tumor-Associated, Carbohydrate / Cancer Vaccines Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2000 Document type: Article Affiliation country: Italia Country of publication: Alemania
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligosaccharides / ABO Blood-Group System / Antigens, Tumor-Associated, Carbohydrate / Cancer Vaccines Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2000 Document type: Article Affiliation country: Italia Country of publication: Alemania